A pharmaco-clinical study to evaluate the effectiveness of Durvadi Tail (Cynodon dactylon(l.)pers.) in the management of Vicharchika w.s.r. to Eczematous Dermatoses
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- To compare the efficacy of Durvadi Tail in the management of Vicharchika with special reference to Eczematous Dermatoses.
研究概览
简要总结
This is the Randomised, comparative clinical study Phase 2 Parellel group trial. Comparing the efficacy of Durvadi Tail and Clobetasol Propionate Ointment in the management of Vicharchika with special reference to Eczematous Dermatoses for 2 months in 60 patients. The patient fulfilling the clinical criteria for diagnosis of Vicharchika will be randomly selected form OPD and IPD of State Ayurvedic College and Hospital, Lucknow and referred cases from other hospitals. A careful history taking, physical examination and necessary investigations will be performed. Further patient divided into two groups,Group A-In this group patient will be treated with Clobetasol Propionate Ointment for local application for 2 months twice in a day. Group B-In this group patient will be treated with Durvadi Tail for local application for 2 months twice in a day.Follow up period will be 15 days after the completion of trail.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 70.00 Year(s)（—）
- 性别
- All
入选标准
- •1- Age group: Between 18 to 70 years.
- •2- The patients with classical lakshana(s) of Vicharchika irrespective of chronicity will be selected.
- •3- Both new and chronic cases of Vicharchika w.s.r. to ECZEMATOUS DERMATOSES will be treated, and 4- Patients willing to participate in above mentioned trial.
排除标准
- •1- Age group: Less than 18 years and more than 70 years 2- Any sensitivity reaction to the preparation 3- Skin cancer, psoriasis, etc associated with fungal infection 4- Pregnant and lactating women 5- Diabetics and immune compromised people.
结局指标
主要结局
To compare the efficacy of Durvadi Tail in the management of Vicharchika with special reference to Eczematous Dermatoses.
时间窗: Patient | enrolled in this group will be evaluated for the outcomes after 2 month of the | therapy.
次要结局
- To examine the drug of sample DURVA for the pharmacognostical(properties & comparing it with the standard sample given in API.)
研究者
Dr Aakriti
State Ayurvedic College and Hospital,Lucknow